Skip to main content
Close

Opioid substitution therapy and mental health counselling help prevent hepatitis C reinfection

Use this image as both the current Page Image and for News listings

Vancouver – Rates of hepatitis C reinfection among people who inject drugs are significantly reduced in those receiving opioid substitution therapy and mental health counselling.

That was one of the findings of a new BC Centre for Disease Control (BCCDC) study published in The Lancet Gastroenterology & Hepatology. The study, Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study is available online.

The BCCDC hepatitis team, using its landmark dataset - BC Hepatitis Testers Cohort (BC-HTC) conducted the study to assess the role of various interventions in preventing hepatitis C (HCV) reinfection among those injecting drugs. 

The study found that receiving opioid substitution therapy and being engaged with mental health counselling services were independently associated with a significantly lower likelihood of HCV reinfection.

Read the full news release on this research and the article, Islam N, et al. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort studyThe Lancet Gastroenterology & Hepatology, December 22, 2016.

Contact:

Ben Hadaway
Communications Officer
BC Centre for Disease Control
604-707-2412 or PHSA media line 778-867-7472
Research; BC Centre for Disease Control
Research
SOURCE: Opioid substitution therapy and mental health counselling help prevent hepatitis C reinfection ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © Provincial Health Services Authority. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority